Rare clot risk linked to Johnson & Johnson COVID-19 vaccine should be explained to younger women, CDC says
April 28 2021, 08:00
Patients should be informed of a rare but serious clotting risk following vaccination with Johnson & Johnson’s single-dose COVID-19 jab, especially women under the age of 50, federal health authorities warn.
Patients should be informed of a rare but serious clotting risk following vaccination with Johnson & Johnson’s single-dose COVID-19 jab, especially women under the age of 50, federal health authorities warn.
Source:
FOX News